<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="recognize">
            <roleset id="recognize.01" name="" wordnet="3">
                <roles>
                    <role n="0" descr="agent&#x0A;" />
                    <role n="1" descr="thing being identified&#x0A;" />
                </roles>
                <example src="EGRAM" no="0">
                    <text>A0 (the upstream eukaryotic binding factor (UBF) will recognize the ribosomal RNA promoter and activate the RNN polymerase I-mediated transcription through cooperative interactions with the species-specific factor, SL1.</text>
                    <arg n="1">the ribosomal RNA promoter</arg>
                </example>
                <example src="EGRAM" no="1">
                    <text>Paperprinting tests have suggested that these regulators protect a segment of up to 20 bp in target promoters, and various alignments of binding sites for a number of regulators have shown that proteins can recognize short reasons within the protected region.</text>
                    <arg n="0">proteins</arg>
                    <arg n="1">short reasons within the protected region</arg>
                </example>
                <example src="PERMUTATE" no="1">
                    <text>A0 (the eukaryotic binding factor upstream (UBF), has recognized sequence (YPYDVPDYA) in a 1:500 dilution and activated the RNA polymerase I-mediated transcription through cooperative interactions with the specific factor of the species, SL1.</text>
                    <arg n="1">sequence (YPYDVPDYA) in a 1:500 dilution</arg>
                </example>
                <example src="PERMUTATE" no="2">
                    <text>D1 antibody of human autoantigen anti-64kD recognized polypeptide approximately 70kD in the western muscles of the extraocular muscle, sternotirio muscle and smooth muscle.</text>
                    <arg n="0">D1 antibody of human autoantigen anti-64kD</arg>
                    <arg n="1">polypeptide approximately 70kD in the western muscles of the extraocular muscle, sternotirio muscle and smooth muscle</arg>
                </example>
                <example src="PERMUTATE" no="3">
                    <text>Footprint tests have suggested that these regulators protect a stretch of up to 20 bp in goal promoters, and multiple alignments of binding sites for a number of regulators have shown that anti-Stat3 pAb can recognize the lowest form of Stat3, Stat3Beta.</text>
                    <arg n="0">anti-Stat3 pAb</arg>
                    <arg n="1">the lowest form of Stat3, Stat3Beta</arg>
                </example>
                <example src="PERMUTATE" no="4">
                    <text>Footprint tests have suggested that these regulators protect a tranche of up to 20 bp in goal promoters, and multiple alignments of binding sites for a number of regulators have shown that anti-64kD antibodies of human autoantigen D1 recognized a polypeptide approximately 70kD in western blots of extraocular muscle, sternotirio muscle, and smooth muscle.</text>
                    <arg n="0">anti-64kD antibodies of human autoantigen D1</arg>
                    <arg n="1">a polypeptide approximately 70kD in western blots of extraocular muscle, sternotirio muscle, and smooth muscle</arg>
                </example>
                <example src="PERMUTATE" no="5">
                    <text>Individual cell clones were analyzed for the expression STAT1 by immunofluorescence where epiptopes in the C-terminal of LMP-1 at a dilution 1:200 is recognized by anti-LMP-1 antisembly purified.</text>
                    <arg n="0">anti-LMP-1 antisembly purified</arg>
                    <arg n="1">epiptopes in the C-terminal of LMP-1 at a dilution 1:200</arg>
                </example>
                <example src="PERMUTATE" no="6">
                    <text>Individual cell clones were analyzed for the expression STAT1 by immunofluorescence where polypeptide approximately 70kD in the western muscles of the extraocular muscle, sternotirio muscle and smooth muscle is recognized by D1 anti-64kD human autoantigen.</text>
                    <arg n="0">D1 anti-64kD human autoantigen</arg>
                    <arg n="1">polypeptide approximately 70kD in the western muscles of the extraocular muscle, sternotirio muscle and smooth muscle</arg>
                </example>
                <example src="PERMUTATE" no="7">
                    <text>Individual cell clones were analyzed for the expression STAT1 by immunofluorescence, where the lowest form of Stat3, Stat3Beta was recognized by anti-Stat3 pAb.</text>
                    <arg n="0">anti-Stat3 pAb</arg>
                    <arg n="1">the lowest form of Stat3, Stat3Beta</arg>
                </example>
                <example src="PERMUTATE" no="8">
                    <text>NarL protein has also joined these 727 sites but, unlike NarP, has also recognized heptamers in other arrangements.</text>
                    <arg n="0">NarL protein</arg>
                    <arg n="1">heptamers in other arrangements</arg>
                </example>
                <example src="PERMUTATE" no="9">
                    <text>Paperprinting tests have suggested that these regulators protect a segment of up to 20 bp in target promoters, and various alignments of binding sites for a number of regulators have shown that activating the cAMP-CRP complex has recognized two sites in tsx-p2.</text>
                    <arg n="0">activating the cAMP-CRP complex</arg>
                    <arg n="1">two sites in tsx-p2</arg>
                </example>
                <example src="PERMUTATE" no="10">
                    <text>Printing tests have suggested that these regulators protect a segment of up to 20 bp in goal promoters, and several alignments of binding sites for various regulators have shown that the activator complex cAMP-CRP are able to recognize two sites in tsx-p2.</text>
                    <arg n="0">the activator complex cAMP-CRP</arg>
                    <arg n="1">two sites in tsx-p2</arg>
                </example>
                <example src="PERMUTATE" no="11">
                    <text>The blots were probed with four different specific antibodies that recognized A1 (epitopes in the C muscle of LMP-1 in a 1:200 dilution.</text>
                    <arg n="0">four different specific antibodies</arg>
                </example>
                <example src="PERMUTATE" no="12">
                    <text>The blots were probed with polyclonal anti-LMP-1 purified affinity antiserum recognizing A1 (epitopes in the C muscle of LMP-1 in 1:200 dilution.</text>
                    <arg n="0">polyclonal anti-LMP-1 purified affinity antiserum</arg>
                </example>
                <example src="PERMUTATE" no="13">
                    <text>The epictopes in the C-terminal of LMP-1 at a dilution 1:200 was recognized by the anti-LMP-1 purified affinity antiserum acquired in transduction laboratories (Lexington, KY).</text>
                    <arg n="0">anti-LMP-1 purified affinity antiserum</arg>
                    <arg n="1">epictopes in the C-terminal of LMP-1 at a dilution 1:200</arg>
                </example>
                <example src="PERMUTATE" no="14">
                    <text>The individual cell clones were analyzed for the expression of STAT1 by immunofluorescence, where epiptopes in the C-terminal of LMP-1 at a 1:200 dilution is recognized by anti-LMP-1 anti-LMP-1 purified affinity.</text>
                    <arg n="0">anti-LMP-1 anti-LMP-1 purified affinity</arg>
                    <arg n="1">epiptopes in the C-terminal of LMP-1 at a 1:200 dilution</arg>
                </example>
                <example src="PERMUTATE" no="15">
                    <text>The individual cell clones were analyzed for the expression of STAT1 by immunofluorescence, where the STAT1 N-terminal is recognized by a monoclonal antibody.</text>
                    <arg n="0">a monoclonal antibody</arg>
                    <arg n="1">the STAT1 N-terminal</arg>
                </example>
                <example src="PERMUTATE" no="16">
                    <text>a monoclonal antibody are able to recognize STAT1 N-terminus in regulated promoters.</text>
                    <arg n="0">a monoclonal antibody</arg>
                    <arg n="1">STAT1 N-terminus</arg>
                </example>
                <example src="PERMUTATE" no="17">
                    <text>activating complex cAMP-CRP has also joined these 727 sites but, unlike NarP, has also recognized two sites in tsx-p2.</text>
                    <arg n="0">activating complex cAMP-CRP</arg>
                    <arg n="1">two sites in tsx-p2</arg>
                </example>
                <example src="PERMUTATE" no="18">
                    <text>anti-64kD antibodies of human autoantigen D1 are able to recognize a polypeptide approximately 70kD in western blots of extraocular muscle, sternotirio muscle, and smooth muscle in regulated promoters.</text>
                    <arg n="0">anti-64kD antibodies of human autoantigen D1</arg>
                    <arg n="1">a polypeptide approximately 70kD in western blots of extraocular muscle, sternotirio muscle, and smooth muscle</arg>
                </example>
                <example src="PERMUTATE" no="19">
                    <text>monoclonal antibody recognized STAT1 N-terminus in regulated promoters.</text>
                    <arg n="0">monoclonal antibody</arg>
                    <arg n="1">STAT1 N-terminus</arg>
                </example>
                <example src="PERMUTATE" no="20">
                    <text>most of the regulators belonging to the AraC/XylS family that recognizes multiple connection site is purchased in transduction laboratories (Lexington, KY).</text>
                    <arg n="0">most of the regulators belonging to the AraC/XylS family</arg>
                    <arg n="1">multiple connection site</arg>
                </example>
                <example src="PERMUTATE" no="21">
                    <text>most regulators belonging to the AraC/XylS family is able to recognize multiple binding sites in regulated promoters.</text>
                    <arg n="0">most regulators belonging to the AraC/XylS family</arg>
                    <arg n="1">multiple binding sites</arg>
                </example>
                <example src="PERMUTATE" no="22">
                    <text>the NarL protein recognized heptamers in other arrangements.</text>
                    <arg n="0">the NarL protein</arg>
                    <arg n="1">heptamers in other arrangements</arg>
                </example>
                <example src="PERMUTATE" no="23">
                    <text>the activator complex cAMP-CRP recognizes two sites in tsx-p2.</text>
                    <arg n="0">the activator complex cAMP-CRP</arg>
                    <arg n="1">two sites in tsx-p2</arg>
                </example>
                <example src="PERMUTATE" no="24">
                    <text>the upstream eukaryotic binding factor (UBF) binds to these sites 7-2-7, but, unlike NarP, it also recognizes the promoter of the RNA ribosomal gene .</text>
                    <arg n="0">the upstream eukaryotic binding factor (UBF)</arg>
                    <arg n="1">the promoter of the RNA ribosomal gene</arg>
                </example>
                <example src="PERMUTATE" no="25">
                    <text>two sites in tsx-p2 is recognized by the activator complex cAMP-CRP that the litters were probed.</text>
                    <arg n="0">the activator complex cAMP-CRP</arg>
                    <arg n="1">two sites in tsx-p2</arg>
                </example>
                <example src="PERMUTATE" no="26">
                    <text>two sites in tsx-p2, cannot is recognized in immunoprecipitatio with activator complex cAMP-CRP, as it is high against a C-terminal region of Stat3 that is missing at Stat3Beta.</text>
                    <arg n="0">activator complex cAMP-CRP</arg>
                    <arg n="1">two sites in tsx-p2</arg>
                </example>
                <example src="REPLACE" no="1">
                    <text>Blots were surveyed with autological serum recognizing epitopes.</text>
                    <arg n="0">autological serum</arg>
                    <arg n="1">epitopes</arg>
                </example>
                <example src="REPLACE" no="2">
                    <text>Class and T cells specific to melanoma is able to recognize a series of Ags in regulated promoters.</text>
                    <arg n="0">Class and T cells specific to melanoma</arg>
                    <arg n="1">a series of Ags</arg>
                </example>
                <example src="REPLACE" no="3">
                    <text>Individual cell clones were analyzed for the expression STAT1 by immunofluorescence where a number of Ags is recognized by Class I melanoma-specific T cells.</text>
                    <arg n="0">Class I melanoma-specific T cells</arg>
                    <arg n="1">a number of Ags</arg>
                </example>
                <example src="REPLACE" no="4">
                    <text>Individual cell clones were analyzed for the expression STAT1 by immunofluorescence, where a series of Ags was recognized by class I melanoma-specific T cells.</text>
                    <arg n="0">class I melanoma-specific T cells</arg>
                    <arg n="1">a series of Ags</arg>
                </example>
                <example src="REPLACE" no="5">
                    <text>The a series of Ags was recognized by the Class I melanoma-specific T cells acquired in transduction laboratories (Lexington, KY).</text>
                    <arg n="0">Class I melanoma-specific T cells</arg>
                    <arg n="1">a series of Ags</arg>
                </example>
                <example src="REPLACE" no="6">
                    <text>The blots were probed with autological serum that can recognize epitopes.</text>
                    <arg n="0">autological serum</arg>
                    <arg n="1">epitopes</arg>
                </example>
                <example src="REPLACE" no="7">
                    <text>We show that Class I melanoma-specific T cells recognized a series of Ags that are separated by 33 bp : a high affinity site (CRP-1) overlaps the region-35, and a low affinity site (CRP-2) focuses on the position-74 bp.</text>
                    <arg n="0">Class I melanoma-specific T cells</arg>
                    <arg n="1">a series of Ags</arg>
                </example>
                <example src="REPLACE" no="8">
                    <text>a number of Ags, could be recognized in the immunoprecipitaiton with Class I melanoma-specific T cells as it was raised against a C-terminal region of Stat3 that is missing at Stat3Beta.</text>
                    <arg n="0">Class I melanoma-specific T cells</arg>
                    <arg n="1">a number of Ags</arg>
                </example>
                <example src="REPLACE" no="9">
                    <text>a series of Ags are recognized by Class and T cells specific to melanoma with which the wires were probed.</text>
                    <arg n="0">Class and T cells specific to melanoma</arg>
                    <arg n="1">a series of Ags</arg>
                </example>
                <example src="REPLACE" no="10">
                    <text>a series of Ags is recognized by Class and T cells specific to melanoma.</text>
                    <arg n="0">Class and T cells specific to melanoma</arg>
                    <arg n="1">a series of Ags</arg>
                </example>
                <example src="REPLACE" no="11">
                    <text>a series of Ags, was unrecognized in immunoprecipitatio with class I melanoma-specific T cells, because it is susceptible to a C-terminal region of Stat3 that is recognized in Stat3Beta.</text>
                    <arg n="0">class I melanoma-specific T cells</arg>
                    <arg n="1">a series of Ags</arg>
                </example>
                <example src="REPLACE" no="12">
                    <text>cooled-terminal epitopes, was unrecognized in immunoprecipitatio with one of two monoclonal antibodies, because it is susceptible to a C-terminal region of Stat3 that is recognized in Stat3Beta.</text>
                    <arg n="0">one of two monoclonal antibodies</arg>
                    <arg n="1">cooled-terminal epitopes</arg>
                </example>
                <example src="REPLACE" no="13">
                    <text>the reverse transcription apparatus has also joined these 727 sites but, unlike NarP, has also recognized the normal junction of slice.</text>
                    <arg n="0">the reverse transcription apparatus</arg>
                    <arg n="1">the normal junction of slice</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
